 Canadian cannabis giant Tilray, Inc. NASDAQ:TLRY TSX:TLRY confirmed Thursday that its medical subsidiary Aphria has launched medical cannabis oral strips in THC and CBD-rich varieties. Tilrays medical brands, Aphria, Symbios, and Tilray, are relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings, GMP-certified cultivation, and the earned trust of the medical community, Irwin D. 